News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 1107
- Sources here
- 18
- Companies here
- 17
Search results
Stored financial headlines
Active search
1107 matching headlines
Ticker or company: GICMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Lightwave Logic, Inc. Q2 2026: Revenue $32.8K, Net loss $6.61M, EPS $(0.04) — 10-Q Summary
Lightwave Logic, Inc. reported its Q2 2026 financial results, showing a modest increase in revenue to $32.8K, up from $25.6K in Q2 2025. The company's net loss widened to $6.614M, compared to $4.967M in the prior-year quarter, while basic and diluted loss per share …
LWLG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +216.7% · Next-week setup negative 41.9%
NEXPOINT DIVERSIFIED REAL ESTATE TRUST 3Q 2026: Revenue $19.3M, EPS $0.06— 10-Q Summary
NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT) reported its Q3 2026 results, showing revenue of $19.3 million and diluted FFO per share of $0.06. The company achieved net income attributable to common shareholders of $0.06 million, a significant improvement from a loss in the prior …
NXDT
main company
Sharemaestro market context
Trend signal active
52 weeks +45.1%
Sagicor Financial Q2 Earnings Call Highlights
This article first appeared on GuruFocus. Core Earnings to Shareholders: $34 million in Q2 2026, up from $25 million in Q1 2026. Net Income to Shareholders: $87 million, benefiting from favorable interest rate movements and strong equity markets. Annualized Core ROE: 13.6% for Q2, …
SFC
main company
Sharemaestro market context
Price below Trend Line
52 weeks +10.9%
Lightwave Logic (NASDAQ: LWLG) deepens R&D investment with $95.9M liquidity
Lightwave Logic (NASDAQ: LWLG) reported a wider net loss of $6.6 million for Q2 2026 and $12.9 million for the six-month period, primarily due to increased investment in R&D and general and administrative costs. Despite the losses, the company significantly strengthened its liquidity to …
LWLG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +216.7% · Next-week setup negative 41.9%
UBS Adjusts Price Target on STAAR Surgical to $19 From $20, Keeps Sell Rating
UBS has adjusted its price target for STAAR Surgical Company (STAA) to $19, down from $20, while maintaining a Sell rating on the stock. This update reflects the analyst's current outlook on the medical equipment company. The article also notes recent company activities including …
STAA
main company
Sharemaestro market context
Trend signal active
52 weeks -6.0% · Next-week setup negative 40.7%
ADMA|ADMA Biologics Inc|Price:9.410|Chg%:-0.370
This article provides a detailed overview of ADMA Biologics Inc. (ADMA) stock, including its current price, market performance, key financial figures, and analyst ratings. It also offers technical analysis, company profile, ownership breakdown, and related instruments in the pharmaceutical sector.
ADMA
main company
Sharemaestro market context
Price below Trend Line
52 weeks -46.8%
Global Industrial To Go Ex-Dividend On August 17th, 2026 With 0.28 USD Dividend Per Share
Global Industrial is set to go ex-dividend on August 17th, 2026. Shareholders will receive a dividend of 0.28 USD per share. This indicates an upcoming payout to investors holding the company's stock before the ex-dividend date.
GIC
main company
Sharemaestro market context
Trend signal active
52 weeks +10.3% · Next-week setup positive 55.5%
6 Green Days In A Row: AbCellera Biologics Stock Is Up 85%
AbCellera Biologics (ABCL) stock has surged 85% over six consecutive trading days, reaching a new 52-week high and adding $1.5 billion to its market value. While its revenue growth is strong at 101.3% over the last twelve months, the company faces profitability challenges with …
ABCL
main company
Sharemaestro market context
Trend signal active
52 weeks +159.2% · Next-week setup positive 57.0%
Earnings call transcript: Companhia Siderúrgica Nacional posts Q2 2026 beat By Investing.com
Companhia Siderúrgica Nacional (CSN) reported stronger-than-expected Q2 2026 results, exceeding Wall Street forecasts for both earnings and revenue, driven by improved performance across its diversified segments including steel, mining, cement, logistics, and energy. The company also achieved positive free cash flow and a modest …
SID
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.4%
QuickLogic (QUIK) Stock Price Faces Valuation Reset Despite Narrower Losses
QuickLogic (QUIK) stock dropped approximately 4% despite narrower losses in its Q2 2026 earnings report, indicating a valuation reset by investors. The company's revenue increased, and net loss narrowed, but delays in key contracts and the removal of an Intel ASIC design from its …
QUIK
main company
Sharemaestro market context
Trend signal ended
52 weeks +125.8%
Companhia Siderúrgica Nacional 2026 Q2 - Results - Earnings Call Presentation (NYSE:SID) 2026-08-13
Companhia Siderúrgica Nacional (SID) released its Q2 2026 earnings call presentation on August 13, 2026. The company reported an EPS of -$0.12, missing estimates by $0.09, and revenue of $2.18 billion, which beat estimates by $29.47 million and represented a 12.86% year-over-year increase. The …
SID
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.4%
STAAR Surgical (STAA) Stock Price Shrugs Off Profit Rebound As China Dominates
STAAR Surgical reported a strong Q2 2026, returning to profit with $8.1 million in net income and $93.5 million in sales, largely driven by significant growth in China. Despite these positive results, the stock price barely moved, reflecting investor concerns about the company's heavy …
STAA
main company
Sharemaestro market context
Trend signal active
52 weeks -6.0% · Next-week setup negative 40.7%
Sagicor Financial Co Ltd (SGCFF) (Q2 2026) Earnings Call Highlights: Core Earnings Surge to ...
This article first appeared on GuruFocus. Core Earnings to Shareholders: $34 million in Q2 2026, up from $25 million in Q1 2026. Net Income to Shareholders: $87 million, benefiting from favorable interest rate movements and strong equity markets. Annualized Core ROE: 13.6% for Q2, …
SFC
main company
Sharemaestro market context
Price below Trend Line
52 weeks +10.9%
Jefferies cuts STAAR Surgical stock price target on estimate update
Jefferies has lowered its price target for STAAR Surgical (NASDAQ:STAA) to $28 from $29, while maintaining a Hold rating, following the company's second-quarter 2026 results. STAAR Surgical reported Q2 revenue of $93.5 million, beating consensus estimates, with strong China sales, but missed earnings per …
STAA
main company
Sharemaestro market context
Trend signal active
52 weeks -6.0% · Next-week setup negative 40.7%
Lightwave Logic (NASDAQ:LWLG) Stock Price Down 7% - What's Next?
Lightwave Logic (NASDAQ:LWLG) shares dropped 7% during mid-day trading to $7.45, falling below its 50-day and 200-day moving averages. Analyst sentiment is predominantly negative, with several firms reiterating "Sell" ratings due to weak financial performance, including a quarterly loss of $0.04 per share and …
LWLG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +216.7% · Next-week setup negative 41.9%
AbCellera Biologics Inc. • Robinhood Token (ABCL) Price Prediction for 2026 to 2031
This article provides price predictions for AbCellera Biologics Inc. • Robinhood Token (ABCL) from 2026 to 2045, based on Bybit AI's analysis of user-driven Consensus Ratings and historical patterns. It forecasts a positive trend for ABCL's price, with significant potential ROI over the years, …
ABCL
main company
Sharemaestro market context
Trend signal active
52 weeks +159.2% · Next-week setup positive 57.0%
Can Asceniv Help ADMA Stock Combat IG Market Challenges?
ADMA Biologics ADMA is a U.S.-based commercial-stage biopharmaceutical company focused on developing, manufacturing and marketing specialty biologics for immunodeficient patients and individuals at risk of certain infectious diseases. The company currently markets three FDA-approved plasma-derived biologics: Asceniv (immune globulin intravenous – slra 10% liquid) …
ADMA
main company
Sharemaestro market context
Price below Trend Line
52 weeks -46.8%
Companhia Siderurgica Nacional S.A. Stock 12‑Month Price Target Raised to $1.54, Implies 78% Upside
The 12-month average price target for Companhia Siderurgica Nacional S.A. (CSNA3) stock has been raised from $1.53 to $1.54 by 11 analysts, with a potential upside of 78% based on the August 12 closing price. Despite the increased price target, the consensus rating for …
SID
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.4%
STAAR Surgical Company Q2 2026 Earnings Call Summary
STAAR Surgical reported record first-half revenue, driven by the successful launch of EVO Plus in China, which helped gain market share despite a challenging refractive market. The company is strategically shifting to a platform approach, with plans for new product development and a transition …
STAA
main company
Sharemaestro market context
Trend signal active
52 weeks -6.0% · Next-week setup negative 40.7%